CENTRAL LABORATORIES FEATURED ARTICLES
CENTRAL LABORATORIES WHITE PAPERS & ARTICLES
-
![Digital brain, AI, Machine Learning, AI Neural Network-GettyImages-2238702869]( "AI, Open Source, & the Future of Biostatistics")
AI, Open Source, & the Future of BiostatisticsAI and open-source tools are changing statistical programming. Learn how to validate, govern, and apply them without sacrificing the accuracy and oversight clinical research demands.
-
![Digital Twins Technology-GettyImages-1494714249]( "Digital Twins: From Protocol Design to Predictive Study Execution")
Digital Twins: From Protocol Design to Predictive Study ExecutionA growing generation of AI-enabled digital twin approaches offers a new path. Instead of treating the protocol as a static document, organizations can model it as a dynamic system.
-
![medical analytics, digital AI interface, DNA insights, machine learning, healthcare-GettyImages-2262212754]( "Accelerating Chronic Disease Clinical Study Reports With AI-Enabled Medical Writing And Expert Oversight")
Accelerating Chronic Disease Clinical Study Reports With AI-Enabled Medical Writing And Expert OversightAI-enabled medical writing can cut clinical study report timelines by up to 70%, helping teams manage growing chronic disease trial documentation without sacrificing quality or oversight.
-
![mobile-app-clinical-trials-GettyImages-1321691686]( "Why Cost Of Delivery, Not Rate, Is The Lever CROs Actually Control")
Why Cost Of Delivery, Not Rate, Is The Lever CROs Actually ControlThis piece breaks down why Agentic AI monitoring, nearly a third of trial cost, resets the economics, and why the first CRO to move first resets the price floor for everyone else.
-
![Data analysis science and big data with AI technology-GettyImages-1979289147]( "Trust In AI Agents Has To Be Earned Continuously, Not Just Once")
Trust In AI Agents Has To Be Earned Continuously, Not Just OnceThis white paper lays out how ongoing performance monitoring, version control, and audit-ready traceability keep agentic AI trustworthy in a regulated environment.
CENTRAL LABORATORIES APPLICATIONS & STUDIES
-
Stabilizing A Biotech Sponsor's Data Management And Biostatistics Functions8/29/2026
Discover how a rapid mid-study data transition rescued an endangered clinical trial, cleaned up compromised data, and secured a critical interim database lock within twelve months.
-
Driving ROI: A Real-Time Clinical Trial Oversight Solution8/3/2026
Sample errors, delays, and query overload drain clinical trial budgets. Learn how real-time data capture can shorten timelines and protect data quality.
-
Accelerating A Schizophrenia Trial While Ensuring Quality7/31/2026
Tight timelines and rising patient targets don't have to derail a trial. See how speed and data quality can work together from enrollment to database lock.
-
Reserving Data Integrity With Retrospective Manual Entry7/5/2026
A look at implementing randomization mid-trial by reconstructing subject and inventory records without disrupting sites or compromising data integrity.
-
A Mission To Expand Recruitment Territory6/11/2026
Learn how a proactive feasibility approach helps sponsors strengthen enrollment forecasting, mitigate risk, and implement timely interventions that improve study execution and clinical development.
CENTRAL LABORATORIES PRODUCTS & SERVICES
Design, build, simulate, and analyze clinical studies in one connected system. Embedded intelligence supports the full lifecycle, from protocol development to closeout.
Signals Clinical streamlines clinical data workflows, reducing the time spent preparing data for analytics. Its comprehensive platform enables the rapid delivery of clinical insights that inform both clinical and operational study decisions.
See our exciting new solution for medical monitors, Revvity Signals Software Signals™ Medical Review which empowers clinical development teams and medical monitors to detect safety signals faster and reduce time to submission by combining innovative medical review workflow with advanced analytics.
Navigating drug safety in the era of innovation-driven medicine
The focus on drug safety and pharmacovigilance has never been more intense. Patient safety remains paramount throughout a product's lifecycle, even as sponsors and marketing authorization holders (MAHs) face increasing complexity in managing safety data. This complexity stems from huge volumes of data generated from scores of diverse sources, much of it rapidly expanding unstructured data. Innovation-driven medicine is a key factor. These dynamics are reshaping the landscape of drug safety, presenting both challenges and opportunities for innovation in pharmacovigilance practices.
Avance Clinical has located its Asia hub operations in Seoul, South Korea which is highly regarded for its advanced technology and scientific and medical excellence.
Enabling organizations of all sizes to transform their business through better use of technology.
The AI-driven process management platform for modern clinical development. Judi unifies fragmented workflows and accelerates execution from protocol to submission.
The Revvity Signals Software Risk-Based Monitoring Solution is the most effective way to leverage data-driven insights to optimize site performance while improving patient safety.
CENTRAL LABORATORIES SOLUTIONS
- Deliver Supply Without Friction. Maintain Control At Every Step
- Meet elo - Your Intelligent Data Companion Inside Elosity®
- A New Blueprint For Transforming Feasibility And Recruitment
- Leading The Way In Patient Payments
- Starting A New Study? This One's For You
- A Simplified, Accessible Solution For Phase I And Phase IV Trials
- ICH E6(R3) Is Here: How Should You Handle It?
- Generate Regulatory-Grade, RWE With Speed And Efficiency
- Enhance Clinical Trial Screening And Improve Patient Matching Accuracy
- Modernize Clinical Research With Continuous Digital Data
VIDEOS
- Governing The Decisions: Where AI Is Hardest, And Where We Already Live
- Live AI Demonstration: 15 Minutes. From Nothing To Validation-Ready
- Clinical Innovations In AI
- Accelerated Recruitment Through AI-Powered Patient Matching At Network Scale
- How Our Organizations Advancements Are Shaping The Future Of RTSM
NEWS
- Avance Clinical Appoints Inaugural Chief Commercial Officer, Reinforcing Global Growth Strategy
- Ypsomed Opens Production Site In China
- Ypsomed Launches YpsoLoop As The First Autoinjector Platform Designed For Circularity
- Ypsomed Expands Offering For Clinical Studies
- Ypsomed Receives The Red Dot Design Award 2026 For YpsoLoop
- Ypsomed Receives FDA Clearance For SmartPilot
- Signant Health Acquires Ametris To Create An End-To-End eCOA And Wearables Platform
- Avance Clinical Announces Asia Pacific And Mainland China Expansion Ahead Of BIO International Convention 2026
- The Ottawa Hospital's Biotherapeutics Manufacturing Centre (BMC) Makes Breakthroughs Break Through As Boreal Biomanufacturing
- Suvoda Patient App Earns "Best Patient Relationship Management Solution" In 2026 MedTech Breakthrough Awards Program
- Quotient Sciences Advances AI-Designed Drug Product Into Clinical Development
- Paradigm Health Announces Collaboration With The FDA To Transform Regulatory Review Of Clinical Trial Data
- Inside Information: Nanoform Signs First Exclusivity Agreement For Ultra-High Concentration Subcutaneous Delivery
- Suvoda Announces Agentic RTSM, Enabling The Reduction Of Clinical Trial Startup Timelines By Up To 80%
- Signant Health Enters Definitive Agreement To Acquire Ametris
- Crucial Data Solutions Expands TrialKit AI With Study Simulation And Validation Capabilities
- AI HealthTech Pioneer Biorce Opens U.S. Offices In Austin To Accelerate Global Expansion
- Signant Health Appoints Specialist Physician And Clinical Research Expert Dr. Graham C. Ellis As Clinical Vice President To Strengthen Metabolic Disease And Diabetes Trial Capabilities
- Suvoda Advances Clinical Trial Financial Planning With Support For Complex Multi-Payee Budgets
- Suvoda Named "Most Innovative Clinical Trial Technology Firm Of 2026"
- Avance Clinical Appoints Liahna Toy To Lead Global Early Phase Center Of Excellence
- Avance Clinical Strengthens Global Oncology Offering With Acquisition Of U.S-Based LumaBridge
- Health Equity Research Goes Global—Without Waiting For Perfect Data
- International Study Confirms Universal Digital Health Framework
- ISPOR Announces New Executive Director
- Quotient Sciences Extends Commercial Manufacturing Partnership For Ultra-Rare Disease Treatment
- Sygnature Discovery Unveils Strategic Rebrand To Cement Status As A Global Drug Discovery Partner
- Suvoda Sets New Standard For Streamlined Patient And Site Experience In Clinical Trials
- Suvoda IRT Named A Leader In Everest Group's RTSM PEAK Matrix®
- Altasciences Announces Chris Perkin Appointed To Board Of Directors; Marie-Hélène Raigneau Appointed Chief Executive Officer